PMC:7647877 / 2528-3763 JSONTXT 9 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T20 0-157 Sentence denotes On December 2019 a new coronavirus (SARS-CoV-2) emerged in Wuhan, China, triggering a pandemic of severe acute respiratory syndrome in humans (COVID-19) [1].
T21 158-296 Sentence denotes Today, the scientific community is investing all the resources available to find any therapy and prevention strategies to defeat COVID-19.
T22 297-428 Sentence denotes At the beginning of this pandemic, it was difficult to identify COVID-19 risk factors, that can be targeted for disease prevention.
T23 429-506 Sentence denotes Working on risk factors can, in fact, prevent infection and improve outcomes.
T24 507-629 Sentence denotes Now it is well known that obesity represents a significant risk factor both for COVID-19 susceptibility and prognosis [2].
T25 630-779 Sentence denotes Applying immunonutrition to obese patients can also prevent hospitalization, representing an additional risk factor for worsening COVID-19 prognosis.
T26 780-961 Sentence denotes Moreover, immunonutrition in obese patients may be a relevant strategy to lower the burden of COVID-19 disease [3], given that obesity affects almost 13% of people in the world [4].
T27 962-1235 Sentence denotes The present umbrella review seeks to answer the question of whether a nutritional approach could be used to enhance the immune system’s response to obesity in patients affected by COVID-19, focusing on the interplay between immunonutrition, inflammation and gut microbiota.